Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation.
Xu ZhouJun ChenHua TaoYujie CaiLidan HuangHaihong ZhouYanyan ChenLili CuiWangtao ZhongKeshen LiPublished in: Neuropsychiatric disease and treatment (2020)
These findings demonstrate that intranasal delivery of miR-155-5p antagomir alleviated acute seizures, likely by blocking hippocampal inflammation. However, other potential mechanisms of the effects of miR-155-5p antagomir and its long-term safety for epilepsy treatment remain to be investigated.